See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2020_BIOSPECIFICS_TECHNOLOGIES_CORP.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000875622')"} |
Graph
Absolute values for 0000875622, BIOSPECIFICS TECHNOLOGIES CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 109,271,476 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 573,277 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 16,808,515 |
| 4 | LiabilitiesCurrent | 1,422,492 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,285,372 |
| 9 | ResearchAndDevelopmentExpense | 590,331 |
| 10 | remainder_Expenses | 5,828,840 |
| 11 | remainder_Revenues | 38,187,755 |
| 12 | remainder_NetIncome | 1,986,596 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 126,653,268 |
| 1 | Liabilities | 1,422,492 |
| 2 | Expenses | 15,704,543 |
| 3 | Revenues | 38,187,755 |
| 4 | StockholdersEquity | 125,230,776 |
| 5 | NetIncome | 24,469,808 |
| 6 | ComprehensiveNetIncome | 24,469,808 |
| 7 | BaseVar | 91,977,327 |
| 8 | EconomicCapitalRatio | 3.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
